Clinical research is at the heart of all medical advances and contributes greatly to improving the quality of medicine that is available to you and your loved ones. Participants in research studies — people just like you — are a critical link to making these discoveries possible.
Austin Regional Clinic (ARC) is currently enrolling patients in the below studies. Both ARC patients and non-ARC patients who fit trial eligibility requirements are welcome to apply.
ARC Clinical Research enrolling studies
- BaxDuo Pacific Chronic Kidney Disease (CKD) Clinical Study: A phase III, randomized, double-blind, active-controlled study intended to assess the efficacy, safety, and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on chronic kidney disease (CKD) progression and cardiovascular events in participants with CKD and high blood pressure.
- ENABLE Multiple Sclerosis (MS) Clinical Study: A long-term observational registry study for patients with multiple sclerosis (MS) to collect real-world data on BRIUMVI (infusion medication) and assess efficacy, safety, and tolerability of medication.
- Pediatric Migraine Clinical Study: A phase III, multicenter, randomized, double-blind, placebo-controlled, single-attack study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of oral study medication in the acute treatment of migraine with or without aura in children and adolescents (ages 6-17).
Learn more by calling ARC Clinical Research at 737-247-7240 or visit ARCclinicalresearch.com.